A randomized phase II non-comparative study of pemetrexedcarboplatin and gemcitabinevinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients

By                    

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1778-1785

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

By Smorenburg C.H.   Bontenbal M.   Seynaeve C.   Zuylen C.v.   Heus G.d.   Verweij J.   Wit R.d.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 83-87

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer

By Lee S.-H.   Lee J.   Park J.   Park S.   Lee K.-E.   Lee S.   Nam E.   Park J.   Kim K.   Jung C.   Park Y.   Yoon S.   Kang W.   Lee M.   Park K.   Im Y.-H.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 223-231

Humana Press, Inc

Access to resources Recommend Favorite

Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

By Wist Erik   Sommer Hilde   Østenstad Bjørn   Risberg Terje   Bremnes Yngve   Mjaaland Ingvild  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 186-189

Informa Healthcare

Access to resources Recommend Favorite

Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients

By Bascioni R.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 3, 1997-09 ,pp. : 205-210

Springer Publishing Company

Access to resources Recommend Favorite